Sean L O'Brien

US Patent:

20210374184, Dec 2, 2021

Filed:

Aug 16, 2021

Appl. No.:

17/445118

Inventors:

- Redwood City CA, US
Sean O'Brien - Atlanta GA, US

International Classification:

G06F 16/9035
H04L 9/06
G06F 17/18

Abstract:

A computer-implemented method of auditing drug supply chain data gathered from a distributed ledger is disclosed. The method includes receiving a population of drug product records from the distributed ledger. The method includes receiving a first set of drug product criteria. The method includes determining a weighted probability for one or more drug product records of the population of drug product records. The method includes generating a randomized first subset of drug product records from the population of drug product records based on the weighted probability of the one or more drug product records. Other methods, systems, and the like for unbiased drug selection for audit are also disclosed.

US Patent:

20210374860, Dec 2, 2021

Filed:

Aug 10, 2021

Appl. No.:

17/444818

Inventors:

- Redwood City CA, US
Sean O'Brien - Atlanta GA, US
Faried Amani - Atlanta GA, US
Alan Pohl - Doraville GA, US

International Classification:

G06Q 40/04
G06Q 20/38
G06Q 20/06
G06Q 10/08

Abstract:

A method may include storing information in a supply mesh. The supply mesh may include two or more value links. The method may include determining that a first value link of the two or more value links fulfills a value link condition of a second value link. The method may include providing a transaction proposal to the first value link. The transaction proposal may include an amount of private currency. The method may include receiving, from the first value link, a transaction acceptance to the transaction proposal. The method may include transferring the amount of private currency from the second value link to the first value link. The method may include confirming completion of a transaction between the first value link and the second value link. The transaction may be based on the transaction proposal. Other methods and systems are also disclosed.

US Patent:

20200143470, May 7, 2020

Filed:

Oct 31, 2019

Appl. No.:

16/671082

Inventors:

- Redwood City CA, US
Faried Amani - Atlanta GA, US
Maik Lindner - Roswell GA, US
Sean O'Brien - Atlanta GA, US

International Classification:

G06Q 40/04
G06Q 20/06
G06Q 20/38

Abstract:

A method may include storing information in a supply mesh. The supply mesh may include two or more value links. The method may include determining that a first value link of the two or more value links fulfills a value link condition of a second value link. The method may include providing a transaction proposal to the first value link. The transaction proposal may include an amount of private currency. The method may include receiving, from the first value link, a transaction acceptance to the transaction proposal. The method may include transferring the amount of private currency from the second value link to the first value link. The method may include confirming completion of a transaction between the first value link and the second value link. The transaction may be based on the transaction proposal. Other methods and systems are also disclosed.

US Patent:

20190317964, Oct 17, 2019

Filed:

Apr 16, 2019

Appl. No.:

16/385730

Inventors:

- Redwood City CA, US
Sean O'Brien - Atlanta GA, US

International Classification:

G06F 16/9035
G06F 17/18
H04L 9/06

Abstract:

A computer-implemented method of auditing drug supply chain data gathered from a distributed ledger is disclosed. The method includes receiving a population of drug product records from the distributed ledger. The method includes receiving a first set of drug product criteria. The method includes determining a weighted probability for one or more drug product records of the population of drug product records. The method includes generating a randomized first subset of drug product records from the population of drug product records based on the weighted probability of the one or more drug product records. Other methods, systems, and the like for unbiased drug selection for audit are also disclosed.